Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Clinical Development

Global trials growth driving CRO consolidation, says M&A report

29-Jul-2014 - Increased emphasis on global clinical trials is promoting consolidation of contract research organisations (CROs), according to an industry report by M&A services firm 11T Partners.

SRI International wins $49m NIH contract to study new HIV, AIDS therapies

29-Jul-2014 - SRI International was awarded a seven-year, $49m contract from the NIAID (National Institute of Allergy and Infectious Diseases), which is a division of the NIH (National Institutes of Health), for...

Strategic alliances can benefit SMEs as well as Big Pharma, says CRO DZS

28-Jul-2014 - Strategic partnerships are “flexible, cost-effective and will become the trend over the next few years,” says CRO DZS, which has signed a multi-year deal with SBI Pharmaceuticals.

Accovion continues expansions across Europe

23-Jul-2014 - Germany-based full-service CRO (contract research organization) Accovion has expanded European presence with new offices in Italy, France and Eastern Europe. 

Biosimilar trials: the ‘under the radar’ sourcing race

23-Jul-2014 - Timescales and sourcing comparator biologics are the biggest challenges for biopharmas running biosimilars studies, says an expert.

CRO SynteractHCR recognized by Swiss for clinical training program

22-Jul-2014 - A Swiss association has recognized the European Centre for Clinical Research Training (ECCRT), a SynteractHCR company, for training investigators and sub-investigators on GCP (good clinical practice).  

Indian clinical trial approvals see early spike in 2014

21-Jul-2014 - The approval of clinical trials in India is rebounding in 2014 after a year in which the country’s regulations were in constant flux.

ACRES, inVentiv partner to help develop global trial standards

17-Jul-2014 - CRO inVentiv’s Clinical Trial Recruitment Solutions (iCTRS) and the non-profit Alliance for Clinical Research Excellence and Safety (ACRES) are partnering to accelerate the development of a global standards system to...

FDA offers new draft guidance on informed consent process

17-Jul-2014 - For the first time since 1998, the US FDA is offering draft guidance on what it expects from IRBs (institutional review boards), clinical investigators and sponsors regarding informed consent.


Theorem pushes further into India as regulatory hurdles mount

16-Jul-2014 - CRO Theorem Clinical Research and Excel Life Sciences have formed a strategic relationship to bolster Theorem’s clinical development offerings in India just as regulations begin to shift on the subcontinent....

Chiltern taps oncology expertise with Ockham acquisition

16-Jul-2014 - UK-based CRO Chiltern has agreed to acquire Ockham, a North Carolina-based full-service CRO, and the combined company will now compete with mid-sized CROs. Financial terms of the acquisition were not...

CROs see high jobs growth as bio industry remains relatively flat, report finds

15-Jul-2014 - While the overall bioscience industry has seen 7.4% jobs growth between 2001 and 2012, the sector encompassing CROs and other research, testing and medical labs has grown by more than...

ACRO offers new ways to keep US research competitive

14-Jul-2014 - The Association of Clinical Research Organizations (ACRO) offered a number of recommendations to the US House Energy and Commerce Committee’s “21st Century Cures” initiative last week as part of an...

EMA delays policy on clinical trial data transparency

10-Jul-2014 - The Management Board of the EMA (European Medicines Agency) has postponed the formal adoption of its policy on publication of clinical trial data, though the agency stopped short of revealing exactly why. ...

Ophthamology CRO becomes shareholder of Nicox following $65m acquisition

09-Jul-2014 - European drugmaker Nicox has agreed to acquire all of the outstanding equity of US-based Aciex Therapeutics, an ophthalmic development company, which will also be a boon for ophthalmic CRO Ora. ...

Include prisoners in clinical trials, say European scientists

09-Jul-2014 - Scientists and ethicists have called for changes to European guidance which excludes prisoners from clinical trials.

Declaration of Helsinki revisions weaken patient protections, researchers say

08-Jul-2014 - The latest draft revisions of the Declaration of Helsinki (DoH) weaken protections for trial participants in low and middle income countries, Rafael Dal-Ré, director of clinical research at Universidad Autónoma de...

CDSCO issues raft of new trial regulations

07-Jul-2014 - Sponsors and CROs must ensure that clinical studies are properly designed and that investigators work on a maximum of three trials simultaneously under new guidelines issued by Indian regulators.

CRO research roundup: Partnership, grant and milestone

07-Jul-2014 - Contract research organizations have seen a number of recent partnerships, grants and milestone payments. Here’s a quick round up of recent deals:

Petition calls on FDA to amend informed consent requirements

03-Jul-2014 - The Center for Responsible Science  has asked the US FDA to adopt informed consent rules which ensure that trial participants know the experimental drugs they receive may be unsafe or ineffective....

Quintiles completes Encore analytics acquisition

02-Jul-2014 - Quintiles announced yesterday it has completed the acquisition of Encore Health Resources, a health information analytics and technology consultancy.

Parexel taps Middle East, North Africa with Atlas acquisition

02-Jul-2014 - CRO Parexel has shifted its attention overseas with the acquisition of Atlas Medical Services, a provider of clinical research services in Turkey, the Middle East, and North Africa. 

Trial documents: only 13% of firms are fully paperless, says Veeva

01-Jul-2014 - Contract research organisations (CROs) have been slow to adopt next-generation means of recording study documents, with only 13% using the most up-to-date technologies, according to cloud-based services company Veeva.

Dispatches from DIA

Pfizer offers update on risk-sharing deals with Icon, Parexel

30-Jun-2014 - Three years after Pfizer began strategic partnerships with CROs Icon and Parexel, and the companies are still ironing out differences and tweaking their relationships, Mark Sanders, senior director of global...

Dispatches from BIO 2014

Small biotech experts offer cautious approach to CRO use

26-Jun-2014 - Small biotechs thinking of outsourcing should carefully weigh up the pros and cons say industry experts, who warn that for firms that do contract out clinical development choosing the right...

Key Industry Events


Access all events listing

Our events, Events from partners...